ViaDerma, Inc

Novum Pharmaceutical Research Services is a distinguished contract research organization (CRO) with over 50 years of experience in delivering comprehensive clinical research solutions to the global biotech and pharmaceutical industries. Acquired by Lambda Therapeutic Research in 2019, Novum operates under a unified brand, leveraging a vast network and substantial therapeutic expertise to effectively manage multi-centric clinical programs across various therapeutic areas. With a robust track record of FDA approvals, Novum offers end-to-end services that encompass early-phase to late-phase clinical trial management, scientific affairs, and bioanalytical support. The company is committed to upholding the highest standards of integrity and innovation while consistently exceeding client expectations in drug development programs. Generated from the website

Skinvisible Pharmaceuticals develops, licenses and markets innovative polymer delivery vehicles and related compositions that are topically applied and hold active ingredients on the skin for up to four hours. The company s primary objective is to license its patented technology and sell its trademarked polymer delivery vehicles to established brand manufacturers, including marketers of prescription and over-the-counter products in the dermatological, medical, cosmetic and skincare markets. The company also produces a variety of products that incorporate its technology for private label clients, including antimicrobial hand sanitizers, sunless tanning sprays, sunscreens and skincare products. Skinvisible Pharmaceuticals maintains its research and development facility and corporate offices in Las Vegas.